Status:
UNKNOWN
Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease
Lead Sponsor:
Oregon Health and Science University
Conditions:
Parkinson Disease
REM Sleep Behavior Disorder
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective observational study investigating the utility of 7 Tesla MRI to quantify nigrosome1 signal in a cohort of individuals with recent onset Parkinson's disease and in at-risk cohorts...
Eligibility Criteria
Inclusion
- Idiopathic Parkinson's disease within 1 year of motor symptom onset. Idiopathic REM sleep behavior disorder without signs/symptoms of Parkinson's disease.
- Age-matched controls.
Exclusion
- Atypical Parkinsonism
- Contraindications for MRI
Key Trial Info
Start Date :
September 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2021
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03288909
Start Date
September 1 2015
End Date
January 1 2021
Last Update
June 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239